NR 546 Week 3 Discussion.
Dr. bOkpaleke band bClass,
In bthe bcase bof bLM bpresenting bwith bchief bcomplaints bof bhearing bvoices bwith bno bpast bpsychiatric
bhistory bbut ba bpositive bfamily bhistory bof bsuicide band bsubstance babuse. bLM bis bdiagnosed bwith
bF20.9bSchizophrenia, bunspecified. bAccording bto bStahl b(2021), bpsychosis bis ba bsyndrome bwith ba
bmixture bof bsymptoms bthat bcan bbe bassociated bwith bdifferent bpsychiatric bdisorders. bFurthermore,
bit bhas bbeenbsaid bthat bpsychosis bis bmeans bdelusions band bhallucinations. bHallucinations bare
bperceptual bexperiences bof bany bsensory bmodality, bespecially bauditory, baccording bto bStahl
b(2021).
The bAPA b(2021) brecommends bthe buse bof bsecond-generation bantipsychotic bmedication bfor bstable
bpatients bpresenting bto boutpatient bsettings, bwhile brecommending bfirst bgeneration bantipsychotics
bforbunstable binpatient buse. bTherefore, bI bchose bChlorpromazine bfor bits btherapeutic buse bas ban boral
bagentbfor bschizophrenia. bChlorpromazine bis ba bconventional bantipsychotic bwhich bworks bas ba
bdopamine band bserotonin breceptor bantagonist b(DS-Ran), baccording bto bStahl b(2020).
The bprescription bfor bthis bmedication bshould bbe bwritten bas bsuch; bpatient bname: bLM, bdate bof
bbirth b01/01/1984, bNKDA, bDrug: bChlorpromazine b25mg btablet bby bmouth bevery bsix bhours bfor
b2 bweeks.bPrescribers bname band bcredentials, bsignature band bdate bof bprescribing.
Chlorpromazine bhas bbeen bused bin btreating bSchizophrenia’s bpositive bsymptoms band bis bused
bto bmanage band btreat bschizophrenia, bbipolar bdisorders, band bacute bpsychosis, baccording bto
bMann b&bMarwaha b(2021).
According bto bStahl b(2020), bside beffects bof bChlorpromazine bare bdose brelated, bhowever bthe
bnotable bside beffects bare bdizziness, bsedation, bimpaired bmemory, bdry bmouth, bconstipation, burinary
bretention,bblurred bvision, bdecreased bsweating, bsexual bdysfunction, bweight bgain, band btardive
bdyskinesia.
The brequired bdiagnostic btesting bfor bChlorpromazine bincludes bobtaining bbaseline bweight band
bBMIbof bpatient, bobtaining bbaseline bdiabetes btesting bsuch bas bfasting bplasma bglucose, bas bwell bas
btesting bbaseline blipid bpanel, bobtain bbaseline bmetabolic bpanel, bcomplete bblood bcount band
bprolactin blevels,band bfinally, bobtain bbaseline bvital bsigns band bmonitor bfor babnormal bmovements
bof btardive bdyskinesia. bNormal bfasting bglucose bshould bbe b100-125mg/dl, bcholesterol blevels
bshould bbe bless bthan b200mg/dl, bnormal bwhite bcount bshould bbe bless bthan b11000 bwbc bper
bmicroliter. bThere bshould bnot bbe bany babnormal bmovements bin bassessing bfor btardive bdyskinesia.
Teaching bfor bChlorpromazine bshould binclude beducation bon bside beffects, beducation bon
bmonitoringbfor btardive bdyskinesia, bmonitoring bweight bgain, bnot btaking bChlorpromazine bwith
bother bCNS bdepressive bsubstances bsuch bas balcohol, bsigns bof ballergies bto bChlorpromazine bsuch
bas bfacial bswelling, bworsening brespiratory bstatus, bconfusion, bor bcomatose bstate. bChlorpromazine
bmay bcausebpostural bhypotension bso bto bget bup bslowly bfrom bbed bor bchair. bAvoid bextreme bheat bor
bundue bexposure bto bsunlight.
Dr. bOkpaleke band bClass,
In bthe bcase bof bLM bpresenting bwith bchief bcomplaints bof bhearing bvoices bwith bno bpast bpsychiatric
bhistory bbut ba bpositive bfamily bhistory bof bsuicide band bsubstance babuse. bLM bis bdiagnosed bwith
bF20.9bSchizophrenia, bunspecified. bAccording bto bStahl b(2021), bpsychosis bis ba bsyndrome bwith ba
bmixture bof bsymptoms bthat bcan bbe bassociated bwith bdifferent bpsychiatric bdisorders. bFurthermore,
bit bhas bbeenbsaid bthat bpsychosis bis bmeans bdelusions band bhallucinations. bHallucinations bare
bperceptual bexperiences bof bany bsensory bmodality, bespecially bauditory, baccording bto bStahl
b(2021).
The bAPA b(2021) brecommends bthe buse bof bsecond-generation bantipsychotic bmedication bfor bstable
bpatients bpresenting bto boutpatient bsettings, bwhile brecommending bfirst bgeneration bantipsychotics
bforbunstable binpatient buse. bTherefore, bI bchose bChlorpromazine bfor bits btherapeutic buse bas ban boral
bagentbfor bschizophrenia. bChlorpromazine bis ba bconventional bantipsychotic bwhich bworks bas ba
bdopamine band bserotonin breceptor bantagonist b(DS-Ran), baccording bto bStahl b(2020).
The bprescription bfor bthis bmedication bshould bbe bwritten bas bsuch; bpatient bname: bLM, bdate bof
bbirth b01/01/1984, bNKDA, bDrug: bChlorpromazine b25mg btablet bby bmouth bevery bsix bhours bfor
b2 bweeks.bPrescribers bname band bcredentials, bsignature band bdate bof bprescribing.
Chlorpromazine bhas bbeen bused bin btreating bSchizophrenia’s bpositive bsymptoms band bis bused
bto bmanage band btreat bschizophrenia, bbipolar bdisorders, band bacute bpsychosis, baccording bto
bMann b&bMarwaha b(2021).
According bto bStahl b(2020), bside beffects bof bChlorpromazine bare bdose brelated, bhowever bthe
bnotable bside beffects bare bdizziness, bsedation, bimpaired bmemory, bdry bmouth, bconstipation, burinary
bretention,bblurred bvision, bdecreased bsweating, bsexual bdysfunction, bweight bgain, band btardive
bdyskinesia.
The brequired bdiagnostic btesting bfor bChlorpromazine bincludes bobtaining bbaseline bweight band
bBMIbof bpatient, bobtaining bbaseline bdiabetes btesting bsuch bas bfasting bplasma bglucose, bas bwell bas
btesting bbaseline blipid bpanel, bobtain bbaseline bmetabolic bpanel, bcomplete bblood bcount band
bprolactin blevels,band bfinally, bobtain bbaseline bvital bsigns band bmonitor bfor babnormal bmovements
bof btardive bdyskinesia. bNormal bfasting bglucose bshould bbe b100-125mg/dl, bcholesterol blevels
bshould bbe bless bthan b200mg/dl, bnormal bwhite bcount bshould bbe bless bthan b11000 bwbc bper
bmicroliter. bThere bshould bnot bbe bany babnormal bmovements bin bassessing bfor btardive bdyskinesia.
Teaching bfor bChlorpromazine bshould binclude beducation bon bside beffects, beducation bon
bmonitoringbfor btardive bdyskinesia, bmonitoring bweight bgain, bnot btaking bChlorpromazine bwith
bother bCNS bdepressive bsubstances bsuch bas balcohol, bsigns bof ballergies bto bChlorpromazine bsuch
bas bfacial bswelling, bworsening brespiratory bstatus, bconfusion, bor bcomatose bstate. bChlorpromazine
bmay bcausebpostural bhypotension bso bto bget bup bslowly bfrom bbed bor bchair. bAvoid bextreme bheat bor
bundue bexposure bto bsunlight.
